Development of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 61, Issue 3, 2005, Pages 134-141

  Huyghebaert, Nathalie ^a   Vermeire, An ^a   Rottiers, Pieter ^b   Remaut, Erik ^b   Remon, Jean Paul ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Eudragit; Inulin; Layering; Recombinant Lactococcus lactis; Viability

Indexed keywords

EUDRAGIT; INTERLEUKIN 10; INULIN;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STORAGE; ENTERIC COATED TABLET; FREEZE DRYING; LACTOCOCCUS LACTIS; MILK; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REACTION TIME; SIMULATION; STOMACH JUICE;

CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; ILEUM; INTERLEUKIN-10; LACTOCOCCUS LACTIS; POLYMETHACRYLIC ACIDS; TABLETS, ENTERIC-COATED; TECHNOLOGY, PHARMACEUTICAL;

EID: 26444444081     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.04.002     Document Type: Article

References (15)

1. S.J.H. van Deventer, C.O. Elson, and R.N. Fedorak Multiple doses of intravenous interleukin-10 in steroid refractory Crohn's disease Gastroenterology 113 1997 383 389
2. H. Tilg, C. van Montfrans, A. van den Ende, A. Kaser, S.J.H. van Deventer, S. Schreiber, M. Gregor, O. Ludwiczek, P. Rutgeerts, C. Gasche, J.C. Koningsberger, L. Abreu, I. Kuhn, M. Cohard, A. LeBeaut, P. Grint, and G. Weiss Treatment of Crohn's desease with recombinant human interleukin-10 induces the proinflammatory cytokine interferon gamma Gut 50 2 2002 191 195
3. L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeirer, W. Falk, W. Fiers, and E. Remaut Treatment of Murine Colitis by Lactococcus lactis secreting interleukin-10 Science 289 2000 1352 1355
4. L. Steidler, K. Robinson, L. Chamberlain, K.M. Schofield, E. Remaut, R.W.F. Le Page, and J.M. Wells Mucosal delivery of murine interleukine-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine Infect. Immun. 66 7 1998 3183 3189
5. K. Vandenbroucke, W. Hans, J. Van Huysse, S. Neiryck, P. Demetter, E. Remaut, P. Rottiers, and L. Steidler Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice Gastroenterology 127 2 2004 505 513
6. L. Steidler, S. Neirynck, N. Huyghebaert, V. Snoeck, A. Vermeire, B.M. Goddeeris, E. Cox, J.P. Remon, and E. Remaut Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin-10 Nat. Biotechnol. 21 7 2003 785 789
7. N. Klijn, A. Weerkamp, and W. Vos Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract Appl. Environ. Microbiol. 61 7 1995 2771 2774
8. J. Krämer, and H. Blume Biopharmaceutical aspects of multi-particulate I. Ghebre-Sellassie Multi-Particulate Oral Drug Delivery 1994 Dekker New York 307 323
9. N. Huyghebaert, A. Vermeire, S. Neirynck, L. Steilder, E. Remaut, and J.P. Remon Evaluation of extrusion/spheronisation, layering and compaction for the production of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis Eur. J. Pharm. Biopharm. 59 1 2005 9 15
10. M. Gasson Plasmid complements of Streptococcus lactis NCDO-712 and other lactic streptococci after protoplast-induced curing J. Bacteriol. 154 1 1986 1 9
11. L.M. Crowe, D.S. Reid, and J.H. Crowe Is trehalose special for preserving dry biomaterials? Bioph. J. 71 4 1996 2087 2093
12. F. Franks Thermomechanical properties of amorphous saccharides: their role in enhancing pharmaceutical product stability Biotechnol. Genet. Eng. 16 1999 281 292
13. W.L.J. Hinrichs, M.G. Prinsen, and H.W. Frijlink Inulin glasses for the stabilisation of therapeutic proteins Int. J. Pharm. 215 2001 163 174
14. N. Huyghebaert, A. Vermeire, S. Neirynck, L. Steidler, E. Remaut, J.P. Remon, Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. Eur. J. Pharm. Biopharm. Accepted for publication.
15. N. Huyghebaert, A. Vermeire, J.P. Remon. In vitro evaluation of coating polymers for enteric coating and human ileal targeting. Int. J. Pharm. Accepted for publication.